Faculty
Lupe G. Salazar, MD
Acting Instructor
Department of Medicine
Division of Oncology
Mailing Address
Tumor Vaccine Group
815 Mercer Street
Seattle, WA 98109
Admin Contact
206.543.8557
Specialty / Expertise
Breast Cancer
Research Interests
N/A
Current Research Projects
Please see www.tumorvaccinegroup.org.
Training
Dr. Salazar received her MD from the University of Minnesota, Minneapolis, MN. She completed her Internal Medicine Residency at the University of Minnesota, Minneapolis, MN. She was a Post-Doctoral Fellow in Oncology at the University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA.
Selected Publications
Kendall, D.M., Rooney, D.P., Smets, Y.F.C., Salazar Bolding, L., Robertson, R.P.: Pancreas Transplantation Restores Epinephrine Response and Symptom Recognition During Hypoglycemia in Patients with Long-standing Type I Diabetes and Autonomic Neuropathy. Diabetes 1997 Feb; 46(2): 249-57.
Ginsburg, A., Salazar, L.G., True, L.D., and Disis, M.L.: Fatal Bacillus cereus sepsis following resolving neutropenic enterocolitis during the treatment of acute leukemia. Amer J of Hematology 2003 Mar; 72(3):204-8.
Salazar L.G., Fikes, J., Southwood, S., Ishioka, G., Knutson K.L., Gooley, T.A., Schiffman K, and Disis M.L.: Immunization of cancer patients with HER-2/neu derived peptides demonstrating high affinity binding to multiple class II alleles. Clin Cancer Res 2003 Nov; 9(15): 5559-5565.
Disis, M.L., Schiffman, K., Guthrie, K., Salazar, L.G., Knutson, K.L., Goodell, V., dela Rosa, C., Cheever, M.A..: Effect of Dose on Immune Response in Patients Vaccinated with a HER-2/neu Intracellular Domain Protein Based Vaccine J Clin Oncol 2004 May; 22 (10):1916 1925.
Goodell V., Salazar L.G., Urban N., Drescher C.W., Gray, H., Swensen, R.E., McIntosh M.W., Disis M.L.: Antibody Immunity to the p53 Oncogenic Protein Is a Prognostic Indicator in Ovarian Cancer J Clin Oncol 2006 Feb; 24: 762 - 768.
Wang, W., Epler, J., Salazar, L.G., Riddell S.R.: Recognition of Breast Cancer Cells by CD8+ Cytotoxic Clones Specific for NY-BR-1. Cancer Res 2006 Jul; 66(13):6826-33.
Last updated: June 2010